196 related articles for article (PubMed ID: 25501833)
21. Aggregation of ALS-linked FUS mutant sequesters RNA binding proteins and impairs RNA granules formation.
Takanashi K; Yamaguchi A
Biochem Biophys Res Commun; 2014 Sep; 452(3):600-7. PubMed ID: 25173930
[TBL] [Abstract][Full Text] [Related]
22. Expression of G protein-coupled receptor 19 in human lung cancer cells is triggered by entry into S-phase and supports G(2)-M cell-cycle progression.
Kastner S; Voss T; Keuerleber S; Glöckel C; Freissmuth M; Sommergruber W
Mol Cancer Res; 2012 Oct; 10(10):1343-58. PubMed ID: 22912338
[TBL] [Abstract][Full Text] [Related]
23. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.
Ito D; Seki M; Tsunoda Y; Uchiyama H; Suzuki N
Ann Neurol; 2011 Jan; 69(1):152-62. PubMed ID: 21280085
[TBL] [Abstract][Full Text] [Related]
24. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
Mackenzie IR; Neumann M
Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
[TBL] [Abstract][Full Text] [Related]
25. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
Prasad DD; Ouchida M; Lee L; Rao VN; Reddy ES
Oncogene; 1994 Dec; 9(12):3717-29. PubMed ID: 7970732
[TBL] [Abstract][Full Text] [Related]
26. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
[TBL] [Abstract][Full Text] [Related]
27. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
28. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
[TBL] [Abstract][Full Text] [Related]
29. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
Strong MJ; Volkening K
FEBS J; 2011 Oct; 278(19):3569-77. PubMed ID: 21810174
[TBL] [Abstract][Full Text] [Related]
30. TLS/FUS (translocated in liposarcoma/fused in sarcoma) regulates target gene transcription via single-stranded DNA response elements.
Tan AY; Riley TR; Coady T; Bussemaker HJ; Manley JL
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6030-5. PubMed ID: 22460799
[TBL] [Abstract][Full Text] [Related]
31. Pur-alpha functionally interacts with FUS carrying ALS-associated mutations.
Di Salvio M; Piccinni V; Gerbino V; Mantoni F; Camerini S; Lenzi J; Rosa A; Chellini L; Loreni F; Carrì MT; Bozzoni I; Cozzolino M; Cestra G
Cell Death Dis; 2015 Oct; 6(10):e1943. PubMed ID: 26492376
[TBL] [Abstract][Full Text] [Related]
32. [Amyotrophic lateral sclerosis (ALS) and fused in sarcoma/translocated in liposarcoma (FUS/TLS)].
Suzuki N; Aoki M
Nihon Rinsho; 2011 Dec; 69 Suppl 10 Pt 2():389-93. PubMed ID: 22755220
[No Abstract] [Full Text] [Related]
33. Mutational analysis of FUS gene and its structural and functional role in amyotrophic lateral sclerosis 6.
Kamaraj B; Rajendran V; Sethumadhavan R; Kumar CV; Purohit R
J Biomol Struct Dyn; 2015; 33(4):834-44. PubMed ID: 24738488
[TBL] [Abstract][Full Text] [Related]
34. Non-coding RNA suppresses FUS aggregation caused by mechanistic shear stress on pipetting in a sequence-dependent manner.
Hamad N; Yoneda R; So M; Kurokawa R; Nagata T; Katahira M
Sci Rep; 2021 May; 11(1):9523. PubMed ID: 33947944
[TBL] [Abstract][Full Text] [Related]
35. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response.
Andersson MK; Ståhlberg A; Arvidsson Y; Olofsson A; Semb H; Stenman G; Nilsson O; Aman P
BMC Cell Biol; 2008 Jul; 9():37. PubMed ID: 18620564
[TBL] [Abstract][Full Text] [Related]
36. RNA sequence and length contribute to RNA-induced conformational change of TLS/FUS.
Hamad N; Mashima T; Yamaoki Y; Kondo K; Yoneda R; Oyoshi T; Kurokawa R; Nagata T; Katahira M
Sci Rep; 2020 Feb; 10(1):2629. PubMed ID: 32060318
[TBL] [Abstract][Full Text] [Related]
37. Loss of the RNA helicase SKIV2L2 impairs mitotic progression and replication-dependent histone mRNA turnover in murine cell lines.
Onderak AM; Anderson JT
RNA; 2017 Jun; 23(6):910-926. PubMed ID: 28351885
[TBL] [Abstract][Full Text] [Related]
38. Liquidizing FUS via prion-like domain phosphorylation.
Shorter J
EMBO J; 2017 Oct; 36(20):2925-2927. PubMed ID: 28963393
[TBL] [Abstract][Full Text] [Related]
39. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP.
Sun S; Ling SC; Qiu J; Albuquerque CP; Zhou Y; Tokunaga S; Li H; Qiu H; Bui A; Yeo GW; Huang EJ; Eggan K; Zhou H; Fu XD; Lagier-Tourenne C; Cleveland DW
Nat Commun; 2015 Jan; 6():6171. PubMed ID: 25625564
[TBL] [Abstract][Full Text] [Related]
40. Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?
Donnelly CJ; Grima JC; Sattler R
Neurodegener Dis Manag; 2014; 4(6):417-37. PubMed ID: 25531686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
